Keratosis
14
2
2
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
29%
4 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead
Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Efficacy and Safety of Ultrapulse Carbon Dioxide Laser Treatment in Eyelid Tumors
Identification of Oral Lesions Through an Autofluorescence System
A Longitudinal Quantitative Assessment of the Effectiveness of Metatarsal Pads on Plantar Pressures
Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / Resection
A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors
Tobacco Cessation Intervention Study for Oral Diseases
The Effect of Efudex Treatment on Photoaged Skin
Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel
Open-Label Safety Study to Evaluate Imiquimod Cream, 5% for Large Areas of Actinic Keratosis
Study of Imiquimod 5% Cream in Addition to Cryotherapy in the Management of Actinic Keratoses
1-Year Follow up to the 1473-IMIQ Study
Study to Assess the Safety and Efficacy of Imiquimod 5% Cream for the Treatment of Actinic Keratosis on the Arms and Hands